Foqus PGCL USP 2.0 Circular Needle

Foqus PGCL USP 2.0 Circular Needle is a latest generation rapid absorption surgical suture thread, specifically designed to ensure excellent wound management and optimal tissue tightness in the post-operative period. Its monofilament structure guarantees fluid sliding through the tissues, minimizing the risk of trauma and promoting orderly healing. The needle, made of the highest quality steel, has a circular shape that allows precise penetration even into the most delicate tissues, significantly reducing the risk of lacerations or tension on the skin and visceral margins. The easy manipulation of the thread, combined with optimal handling of the circular needle, makes this suture ideal for a wide range of surgical procedures. The product is packaged sterilely to ensure maximum safety for both the surgeon and the patient.

The composition of Foqus PGCL USP 2.0 makes it ideal for uses where you want to avoid subsequent removal interventions, because the material is completely absorbed by the body in optimal physiological times. The purple color of the thread allows for easy identification during surgical maneuvers, significantly decreasing operating times and reducing stress for both healthcare personnel and patients. The tensile strength is designed to remain high in the initial days, ensuring tissue cohesion in the delicate phase of the first healing process. Foqus PGCL USP 2.0 Circular Needle is therefore a safe, technologically advanced and versatile choice, capable of responding to the most diverse surgical needs and adapting to the specificities of each individual clinical case.

Therapeutic Indications

Foqus PGCL USP 2.0 Circular Needle finds its ideal indication in all surgical procedures where temporary tissue support is necessary, compatible with a rapid healing process and with a high control of post-operative inflammation. This type of suture is commonly used in general surgery, gynecology, urology, gastroenterology and pediatric surgery, thanks to its reliability and its delicate interaction with the tissues. It is indicated for the closure of cutaneous and subcutaneous wounds and for the suturing of internal organs where adequate initial resistance combined with rapid absorption of the material is required.

In cases of continuous or interrupted sutures, the monofilament nature of the thread drastically reduces the possibility of bacterial colonization compared to multifilament threads, raising safety standards in surgery. It is particularly recommended for pediatric patients or for those with an increased risk of reactions to non-absorbable materials, as it is composed of poliglecaprone 25 with a highly biocompatible profile. Furthermore, the delicate circular needle allows interventions on the most fragile tissues, such as visceral or parenchymal ones, minimizing the risk of collateral damage during penetration and extraction.

Composition

Active ingredient: the suture thread is made entirely of poliglecaprone 25 (PGCL), a synthetic material derived from the copolymerization of glycolide and ε-caprolactone. This composition ensures predictable absorption and minimal inflammatory response. The monofilament ensures a smooth surface which reduces friction in the tissues and lowers the risk of adhesions and infections.

The needle is entirely made of high-resistance medical stainless steel, with circular curvature, atraumatic tip and calibrated for clean cutting. Each component of the product is subjected to rigorous quality and sterilization tests, free of latex and allergenic additives, also ideal for sensitive patients or those with previous allergies. The purple color is obtained using medical, biocompatible and non-migrant pigments, which do not interfere with the wound healing process.

Contraindications

The use of the Foqus PGCL USP 2.0 Circular Needle is contraindicated in all cases where a permanent or long-lasting suture is required, such as in orthopedic implants or cardiovascular sutures where a prolonged hold is necessary. It must not be used in patients already known to be hypersensitive to absorbable synthetic materials of the polyglecaprone family or in situations in which it is not possible to guarantee adequate vascularization of the operating site, because a slowed healing process could lead to a premature loss of the resistance of the thread.

Use is not recommended in areas subject to intense prolonged traction, in particularly compromised tissues or where a serious infection is present, as the inflammatory response or septic environment can accelerate the loss of seal. Caution is also recommended in immunosuppressed patients or with wound healing disorders, where the expected absorption may vary from standards.

Safety of the drug for the species

The Foqus PGCL USP 2.0 Circular Needle has excellent tissue tolerability thanks to its biocompatible profile and monofilament structure which minimizes bacterial contamination. Clinical studies demonstrate that absorption occurs gradually and predictably without significant systemic side effects. Any phenomena of local irritation or inflammation are rare and generally transitory, linked to physiological healing processes and not to an allergic reaction to the material. The degradation products are metabolized safely by the body, without leaving permanent residues in the tissues.

Safety is further increased by disposable and sterile packaging, which limits the possibility of cross-contamination between patients. The hypoallergenic and latex-free material makes the suture also suitable for subjects with previous adverse reactions to medical devices. Management of the suture in the post-operative phase is simple and does not require removal, thus reducing stress for both the patient and the healthcare worker.

Precautions

Before using the Foqus PGCL USP 2.0 Circular Needle it is essential to carefully evaluate the suitability of the suture with respect to the type of tissue to be treated and the patient's clinical conditions. It is suggested to avoid excessive tension on the suture point during tying, in order not to compromise the initial strength of the material. In case of use in contaminated or infected wounds, scrupulous antibacterial prophylaxis and continuous monitoring of the state of the wound in the post-operative period are recommended. It is also necessary to ensure that all the suture material is completely removed in case of any re-operation in the same location.

When handling, always take standard precautions such as sterile gloves and properly disinfected instruments to prevent infection. All thread and packaging residues must be duly disposed of according to current regulations on the management of medical waste. The product must not be reused or re-sterilised, as this would compromise its integrity and safety of use. Finally, check the expiry date and the integrity of the packaging before use.

Method of administration

The Foqus PGCL USP 2.0 Circular Needle Suture must be used with appropriate aseptic techniques to prevent tissue contamination. The thread is pre-loaded on a circular needle and can be used in both continuous and interrupted suture techniques, depending on surgical needs. The circular needle is designed for atraumatic penetration into tissues, reducing pain and risks of bleeding. The fixing of the points must be carried out with secure knots, always taking into account the elasticity and progressive absorption of the material.

In case of high tissue resistance, it is recommended to adapt the number and positioning of stitches to optimize tension distribution and facilitate healing. The thread does not require subsequent removal maneuvers as it is completely reabsorbed within the period indicated by the scientific literature for similar materials. Finally, it is recommended to monitor the sutured area in the days following the operation to evaluate correct healing and intervene promptly in case of complications.

Treatment program

The recommended treatment program for the Foqus PGCL USP 2.0 Circular Needle involves its application in the operating room during surgery, setting the density and distribution of the stitches based on the specific needs of the wound. The thread maintains its tensile strength for a sufficient time to allow physiological healing: it normally guarantees support to the tissues in the first two weeks, after which the process of progressive absorption begins which is completed within 60-90 days. Continuous monitoring of the patient during this period is essential to detect any complications or needs for further interventions.

In the case of patients at risk of dehiscence or with wounds in particularly stressed areas, it may be necessary to increase the number of stitches or evaluate other complementary suturing strategies. Tissue review and evaluation of patient response are an integral part of a successful protocol. It is not necessary to remove the thread once the tissues are completely healed, making this solution particularly suitable in cases where subsequent removal of the suture material is contraindicated or difficult.

Target species

The Foqus PGCL USP 2.0 Circular Needle is intended for human use in hospital and outpatient settings, with the possibility of application also in veterinary surgery in all those domestic or wild animals that require temporary tissue support with reduced risk of foreign body complications. Its high biocompatibility and adaptability to different surgical practices make it a versatile device for general surgeons, specialists and veterinarians involved in the management of acute and chronic wounds, as well as in the suturing of internal organs, bowels, mucous membranes and skin.